These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16468954)

  • 1. Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients.
    Jordan SC; Vo AA; Peng A; Toyoda M; Tyan D
    Am J Transplant; 2006 Mar; 6(3):459-66. PubMed ID: 16468954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation.
    Jordan SC; Vo A; Tyan D; Toyota M
    Trans Am Clin Climatol Assoc; 2006; 117():199-211; discussion 211. PubMed ID: 18528474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
    Jordan SC; Peng A; Vo AA
    Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
    Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J
    J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous polyclonal immunoglobulins (IVIG): what use in transplantation?].
    Haymann JP; Glotz D
    Nephrologie; 1999; 20(3):139-43. PubMed ID: 10418003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Dose Intravenous Immunoglobulin Therapy for Donor Specific Antibodies in Kidney Transplant Recipients with Acute and Chronic Graft Dysfunction: Updates on Previously Reported Cohorts.
    Alfonso J; Gralla J; Klem P; Chan L; Wiseman AC; Cooper JE
    Clin Transpl; 2014; ():161-70. PubMed ID: 26281141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
    Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
    Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications.
    Jordan S; Cunningham-Rundles C; McEwan R
    Am J Transplant; 2003 Jun; 3(6):653-64. PubMed ID: 12780556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of high-dose human immune globulin in highly sensitized patients on the kidney transplant waiting list: one center's experience.
    Gozdowska J; Urbanowicz A; Perkowska-Ptasinska A; Michalska K; Chmura A; Szmidt J; Durlik M
    Transplant Proc; 2009 Oct; 41(8):2997-3001. PubMed ID: 19857660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of antibodies in kidney transplant].
    Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E
    G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro tests to predict response to IVIG in sensitized patients.
    Scornik J
    Am J Transplant; 2006 Jun; 6(6):1497. PubMed ID: 16686780
    [No Abstract]   [Full Text] [Related]  

  • 14. Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab.
    Kahwaji J; Jordan SC; Najjar R; Wongsaroj P; Choi J; Peng A; Villicana R; Vo A
    Transpl Int; 2016 Dec; 29(12):1276-1285. PubMed ID: 27529314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.
    Matignon M; Pilon C; Commereuc M; Grondin C; Leibler C; Kofman T; Audard V; Cohen J; Canoui-Poitrine F; Grimbert P
    PLoS One; 2017; 12(6):e0178572. PubMed ID: 28654684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.
    De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F
    Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection.
    Shin BH; Everly MJ; Zhang H; Choi J; Vo A; Zhang X; Huang E; Jordan SC; Toyoda M
    Transplantation; 2020 Apr; 104(4):856-863. PubMed ID: 31385933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.
    Jordan SC; Vo AA; Toyoda M; Tyan D; Nast CC
    Pediatr Transplant; 2005 Apr; 9(2):155-61. PubMed ID: 15787786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.